Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
Clinical trial NCT05749289 · RECRUITING
Trial details
- NCT number
- NCT05749289
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2028-12-20
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.